Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With Bevacizumab
Condition:   Brain CancerIntervention:   Drug: Palonosetron (Aloxi) and DexamethasoneSponsors:   Duke University;   Eisai Inc.;   National Institute of Neurological Disorders and Stroke (NINDS)Terminated - verified March 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2008 Category: Research Source Type: clinical trials